Inventor · disambiguated record
Patrick Morris
Also filed as: MORRIS PATRICK · MORRIS PATRICK J · MORRIS PATRICK JOSEPH
7 granted patents·5 pending applications·6 citations·filing 2000–2023
75Inventor score
Files withUS HEALTH5UNIV MARYLAND3THALLION PHARMACEUTICALS INC1THE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVIC1THE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEATH AND HUMAN SERVICES1
Top patents by PatentIndex Score
12 records- 0190US11613514B2Crystal forms and methods of synthesis of (2R, 6R)-hydroxynorketamine and (2S, 6S)-hydroxynorketamineUS HEALTH·Filed 2021·Granted Mar 28, 2023·2 cites·15 claims
- 0289US10919842B2Crystal forms and methods of synthesis of (2R, 6R)-hydroxynorketamine and (2S, 6S)-hydroxynorketamineUS HEALTH·Filed 2017·Granted Feb 16, 2021·4 cites·4 claims
- 0375US12473251B2Crystal forms and methods of synthesis of (2R, 6R)-hydroxynorketamine and (2S, 6S)-hydroxynorketamineUS HEALTH·Filed 2023·Granted Nov 18, 2025·0 cites·3 claims
- 0471US11897875B2Deuterated Alpha5 subunit-selective negative allosteric modulators of gamma-aminobutyric acid type a receptors as fast acting treatment for depression and mood disordersUNIV MARYLAND·Filed 2022·Granted Feb 13, 2024·0 cites·10 claims
- 0561US11186539B2Process for synthesis and purification of (2R,6R)-hydroxynorketamineUS HEALTH·Filed 2019·Granted Nov 30, 2021·0 cites·19 claims
- 0659US11459320B2Deuterated Alpha5 subunit-selective negative allosteric modulators of gamma-aminobutyric acid type A receptors as fast acting treatment for depression and mood disordersUNIV MARYLAND·Filed 2018·Granted Oct 4, 2022·0 cites·6 claims
- 0758US2025361230A1LATS Inhibitors and Uses ThereofTHE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEATH AND HUMAN SERVICES·Filed 2023·Application pending·0 cites
- 0853US2023331655A1Hydroxynorketamine compounds and methods of use thereofUNIV MARYLAND·Filed 2021·Application pending·0 cites
- 0950US2021246099A1Process for synthesis and purification of (2r,6r)-hydroxynorketamineTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVIC·Filed 2020·Application pending·0 cites
- 1041US2009186878A1Crystalline forms of a farnesyl dibenzodiazepinoneTHALLION PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 1141US2019083420A1Methods of using (2r, 6r)-hydroxynorketamine and (2s, 6s)-hydroxynorketamine in the treatment of depression, anxiety, anhedonia, fatigue, suicidal ideation, and post traumatic stress disordersUS HEALTH·Filed 2017·Application pending·0 cites
- 1236US6309839B1Screening methods for compounds that inhibit or stimulate helicase enzyme activityUNIV ARKANSAS·Filed 2000·Granted Oct 30, 2001·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Patrick Morris files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →